InvestorsHub Logo
Followers 0
Posts 1326
Boards Moderated 0
Alias Born 01/25/2016

Re: Learjetter post# 44493

Tuesday, 10/15/2019 5:09:12 PM

Tuesday, October 15, 2019 5:09:12 PM

Post# of 113781
Prior scammers notifying us of their trials, via Binghamton Univeristy. Uh oh, in the states....that might entail accountability, oversight, actual action. Not like Canada.

Heres the link:

Look out for adva32a, a derivative of adva27a. Oh how much I know.......

https://content.edgar-online.com/ExternalLink/EDGAR/0001013596-11-000005.html?hash=7bce29fcf205a46707e2ceef835e1061183f3139cd125571118c5a39fefea03c&dest=EXH10-4_HTM#EXH10-4_HTM

2011 the scammers write:

Agreement is to memorialize the terms of our working together with Binghamton University to conduct the necessary research and development to advance our lead compound, Adva-27a (or its derivative, Adva-32a) through various stages of preclinical development, animal studies and Phase I clinical trials for breast cancer and prostate cancer.  The Agreement shall be in force for a period of three (3) years from the Effective Date and shall be renewed automatically for additional one (1) year periods until the Project is completed, unless the research is completed prior to the initial three year term of the Agreement.  The relationship between us and Binghamton University is exclusive in the United States.

Hmmmmmm, this time will be different. Right mate?

Scammers also write they expect plans to cost: $5 million, in 2011. Ha!

All IMO. LOOK OUT FOR ADVA32A, A DERIVATIVE.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News